Elgia Therapeutics, Inc. — Form D
Elgia Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2020-05-05. The offering totals $10.0M, of which $2.3M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2020-05-05
- Form: D
- Accession: 0001811122-20-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $2.3M
- Remaining: $7.7M
- Investors: 2
- Date of first sale: 2020-04-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-366256
Issuer
- Name: Elgia Therapeutics, Inc.
- CIK: 0001811122
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 10686 HUNTERS GLEN DRIVE, SAN DIEGO, CA, 92130
- Phone: 858-336-0916
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Ariel Feldstein | Director | San Diego, CA |
| Brian Hubbard | Director | San Diego, CA |
| Alan Saltiel | Director | San Diego, CA |
| Thomas Coll | Executive Officer | San Diego, CA |
| Ariel Feldstein | Executive Officer | San Diego, CA |
| Alan Saltiel | Executive Officer | San Diego, CA |
More